key: cord-0950247-jrwb9den
authors: MCCABE, Meaghan G.; GERSON, Kristin D.; SRINIVAS, Sindhu K.; HIRSHBERG, Adi
title: Pregnancy Watch: remote monitoring of pregnant and postpartum patients with suspected or confirmed COVID-19
date: 2021-11-08
journal: Am J Obstet Gynecol MFM
DOI: 10.1016/j.ajogmf.2021.100525
sha: c360885688a380b0a5e9138122aecd8608199d44
doc_id: 950247
cord_uid: jrwb9den

nan

As the COVID-19 pandemic emerged in the United States in 2020, providers of pregnant individuals rapidly developed internal guidelines to care for these patients. 1 Consensus among perinatal societies encouraged transition to telehealth when clinically feasible though guidance on how to effectively implement outpatient surveillance was limited, particularly in settings with large patient volume and high disease prevalence necessitating significant resource allocation. 2, 3 To facilitate symptom monitoring for non-pregnant patients with COVID-19 in our health system, Penn Medicine developed an automated text-based surveillance program (COVID WATCH) and paired it with full-time clinician support, similar to a prior automated bi-directional text messaging program developed by our group to monitor postpartum hypertension while reducing health care resource utilization. 4, 5 We concurrently developed a companion program, called Pregnancy Watch, for the obstetric population. The objective of this study was to describe implementation of this remote COVID-19 symptom monitoring program.

This is a retrospective cohort study of pregnant or newly postpartum (less than two 

Two hundred sixty-one patients (239 pregnant and 22 postpartum) enrolled in Pregnancy Watch. Patient characteristics are reported in Table 1 . The majority of participants (71.6%) were self-reported Black, and 67.4% of participants had tested positive for COVID-19.

Two hundred seven (79.3%) patients responded to at least one check-in. Fifty-one (24.6%) responded daily. Sixty-four patients (30.9%) answered the maximum number of text messages. Patients responded on average 8 out of 14 days. Patient engagement did not differ by race (p=0.56), insurance type (p=0.12), parity (p=0.79), or symptom status (p=0.12). When restricting to patients who tested positive for COVID-19, patients responded on average 9 of 14 days.

One hundred and sixty-six (80.2%) patients were managed by the automated program without escalation in care. Of the 42 (19.8%) patients who escalated, nine were directed to obstetric triage (one unable to be reached), and three were admitted due to hypoxia. The mean day of escalation from start of the program was day three.

Sixteen patients escalated more than once during monitoring, of whom three were triaged to in-person assessment and none required admission. Of the 54 patients who did not respond to any text-messages, two presented to the emergency department for worsening symptoms and neither were admitted. No postpartum patients worsened after discharge. When comparing early (first peak, April -May 2020) and late (second peak, November -December 2020) phases of the pandemic, patient engagement and median number of responses did not differ (p=0.31 and p=0.88, respectively).

Implementation of an automated text messaging system for remote symptom monitoring of COVID-19 in the obstetric population was easily adopted with high patient engagement. The majority of individuals were successfully monitored outpatient for worsening clinical disease during their surveillance period. Our program appropriately identified patients with progressive disease warranting in-person evaluation. Similar surveillance programs can support home isolation while reducing exposures and resources needed for follow up, as well as provide patients with reassurance. While continued vaccination efforts will decrease the volume of patients at risk for COVID-19, thereby reducing the need for large-scale surveillance, the recent uptick in COVID-19 cases coupled with emergence of the highly infectious Delta variant, underscore the clinical potential of this type of surveillance strategy in the obstetric population. Data are mean + SD or n(%) unless otherwise specified 

SARS-CoV-2 in Pregnancy: A Comprehensive Summary of Current Guidelines

Management Considerations for Pregnant Patients With COVID-19

Remote Monitoring of Patients with Covid-19: Design, implementation, and outcomes of the first 3,000 patients in COVID Watch